Cargando…

Tumor LINE-1 Methylation Level in Association with Survival of Patients with Stage II Colon Cancer

Genome-wide DNA hypomethylation is associated with a worse prognosis in early-stage colorectal cancer. To measure genome-wide DNA methylation levels, long interspersed nucleotide element (LINE-1) repeats are used as a surrogate marker. Cohort studies on the clinical impact of genome-wide DNA methyla...

Descripción completa

Detalles Bibliográficos
Autores principales:	Swets, Marloes, Zaalberg, Anniek, Boot, Arnoud, van Wezel, Tom, Frouws, Martine A., Bastiaannet, Esther, Gelderblom, Hans, van de Velde, Cornelis J. H., Kuppen, Peter J. K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5297671/ https://www.ncbi.nlm.nih.gov/pubmed/28035987 http://dx.doi.org/10.3390/ijms18010036

Ejemplares similares

The Influence of BRAF and KRAS Mutation Status on the Association between Aspirin Use and Survival after Colon Cancer Diagnosis
por: Frouws, Martine A., et al.
Publicado: (2017)

Methylation associated transcriptional repression of ELOVL5 in novel colorectal cancer cell lines
por: Boot, Arnoud, et al.
Publicado: (2017)

The Homeobox Gene MEIS1 Is Methylated in BRAF (p.V600E) Mutated Colon Tumors
por: Dihal, Ashwin A., et al.
Publicado: (2013)

Characterization of circulating T-, NK-, and NKT cell subsets in patients with colorectal cancer: the peripheral blood immune cell profile
por: Krijgsman, Daniëlle, et al.
Publicado: (2019)

Microsatellite instability in rectal cancer: what does it mean? A study of two randomized trials and a systematic review of the literature
por: Swets, Marloes, et al.
Publicado: (2022)

The effect of aspirin and nonsteroidal anti-inflammatory drug use after diagnosis on survival of oesophageal cancer patients
por: van Staalduinen, Jente, et al.
Publicado: (2016)

BRAF mutation-specific promoter methylation of FOX genes in colorectal cancer
por: van Roon, Eddy H, et al.
Publicado: (2013)

Characterization of novel low passage primary and metastatic colorectal cancer cell lines
por: Boot, Arnoud, et al.
Publicado: (2016)

No association between metformin use and survival in patients with pancreatic cancer: An observational cohort study
por: Frouws, Martine A., et al.
Publicado: (2017)

The Immunogenicity of Colorectal Cancer in Relation to Tumor Development and Treatment
por: de Vries, Natasja L., et al.
Publicado: (2016)

Combined evaluation of the FAS cell surface death receptor and CD8+ tumor infiltrating lymphocytes as a prognostic biomarker in breast cancer
por: Blok, Erik J., et al.
Publicado: (2017)

Age determines the prognostic role of the cancer stem cell marker aldehyde dehydrogenase-1 in breast cancer
por: Mieog, J Sven D, et al.
Publicado: (2012)

Synergistic effects of the sesquiterpene lactone, EPD, with cisplatin and paclitaxel in ovarian cancer cells
por: van Haaften, Caroline, et al.
Publicado: (2015)

Revising the Role of Integrin Subunit β4 Expression in Colon Cancer Progression and Survival
por: Rademaker, Eva, et al.
Publicado: (2022)

High nuclear expression levels of histone-modifying enzymes LSD1, HDAC2 and SIRT1 in tumor cells correlate with decreased survival and increased relapse in breast cancer patients
por: Derr, Remco S, et al.
Publicado: (2014)

The effects of tumor resection and adjuvant therapy on the peripheral blood immune cell profile in patients with colon carcinoma
por: Krijgsman, Daniëlle, et al.
Publicado: (2020)

Allelic Switching of DLX5, GRB10, and SVOPL during Colorectal Cancer Tumorigenesis
por: Boot, Arnoud, et al.
Publicado: (2019)

Epigenetic status of LINE-1 predicts clinical outcome in early-stage rectal cancer
por: Benard, A, et al.
Publicado: (2013)

Histone trimethylation at H3K4, H3K9 and H4K20 correlates with patient survival and tumor recurrence in early-stage colon cancer
por: Benard, Anne, et al.
Publicado: (2014)

Copy number alterations and allelic ratio in relation to recurrence of rectal cancer
por: Goossens-Beumer, Inès J, et al.
Publicado: (2015)

The clinical value of HER-2 overexpression and PIK3CA mutations in the older breast cancer population: a FOCUS study analysis
por: Engels, Charla C., et al.
Publicado: (2016)

Assessment of DNA methylation status in early stages of breast cancer development
por: van Hoesel, A Q, et al.
Publicado: (2013)

Differences between colon and rectal cancer in complications, short-term survival and recurrences
por: van der Sijp, Max P.L., et al.
Publicado: (2016)

Increased PTP1B expression and phosphatase activity in colorectal cancer results in a more invasive phenotype and worse patient outcome
por: Hoekstra, Elmer, et al.
Publicado: (2016)

Early onset MSI-H colon cancer with MLH1 promoter methylation, is there a genetic predisposition?
por: van Roon, Eddy HJ, et al.
Publicado: (2010)

Differences in organization of care are associated with mortality, severe complication and failure to rescue in emergency colon cancer surgery
por: Huijts, Daniëlle D, et al.
Publicado: (2021)

Exploring the Onset and Progression of Prostate Cancer through a Multicellular Agent-based Model
por: Passier, Margot, et al.
Publicado: (2023)

Effect of low-dose aspirin use on survival of patients with gastrointestinal malignancies; an observational study
por: Frouws, M A, et al.
Publicado: (2017)

Combined analysis of HLA class I, HLA-E and HLA-G predicts prognosis in colon cancer patients
por: Zeestraten, E C M, et al.
Publicado: (2014)

No Excess Mortality in Patients Aged 50 Years and Older Who Received Treatment for Ductal Carcinoma In Situ of the Breast
por: Bastiaannet, Esther, et al.
Publicado: (2012)

Biomarkers in precision therapy in colorectal cancer
por: Reimers, Marlies S., et al.
Publicado: (2013)

Präzisions-Elektronik: Grundlagen, Methoden und Schaltungen
por: Klein, G, et al.
Publicado: (1972)

Specific activity of cyclin-dependent kinase I is a new potential predictor of tumour recurrence in stage II colon cancer
por: Zeestraten, E C M, et al.
Publicado: (2012)

Specific activity of cyclin-dependent kinase I is a new potential predictor of tumour recurrence in stage II colon cancer
por: Zeestraten, E C M, et al.
Publicado: (2012)

Integrating chromosomal aberrations and gene expression profiles to dissect rectal tumorigenesis
por: Lips, Esther H, et al.
Publicado: (2008)

A method for semi-automated image analysis of HLA class I tumour epithelium expression in rectal cancer
por: Krijgsman, Daniëlle, et al.
Publicado: (2019)

Combined analysis of HLA class I, HLA-E and HLA-G predicts prognosis in colon cancer patients
por: Zeestraten, E C M, et al.
Publicado: (2014)

Isolated Hepatic Perfusion with 200 mg Melphalan for Advanced Noncolorectal Liver Metastases
por: van Iersel, Liselot B. J., et al.
Publicado: (2008)

Tumor-related neurocognitive dysfunction in patients with diffuse glioma: a systematic review of neurocognitive functioning prior to anti-tumor treatment
por: van Kessel, Emma, et al.
Publicado: (2017)

Lipid phosphatase SHIP2 functions as oncogene in colorectal cancer by regulating PKB activation
por: Hoekstra, Elmer, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_p3c10rl2v0ac3qcmla4ep3cqaq